Heiner Haug

University Paris I Panthéon-Sorbonne
Researcher

Heiner Haug is a researcher in economics at the University of Paris 1(Sorbonne), where he joined the PRISM research unit in 2004. His main interests lie in the economic and strategic dimensions of competition between brand name drugs and generic drugs. Ongoing research projects concentrate on demand behaviour and market structure in post-patent markets for prescription drugs, as well as on pharmaceutical companies’ strategic behaviour and related antitrust issues. Heiner holds a doctorate in economics from Sorbonne University. He graduated from the ESCP-EAP European School of Management in Paris in 2003, after studying in Germany, the UK, Spain and France.

Linked author

French Competition Authority (Paris)

Articles

22136 Review

Emmanuel Combe, Heiner Haug Brand name drugs and generic drugs at war

8485

La guerre économique et juridique que se livrent laboratoires et génériqueurs a connu depuis le début de l’année 2006 de nouveaux développements, qui nous conduisent à actualiser notre étude parue dans le numéro 1-2006 de cette revue. Nous focaliserons notre attention sur deux types de comportements qui (...)

Send a message